section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Concentration and volume not specified.

d Lyophilized formulation tested.

e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

f Tested in sterile water for injection.

g Tested in Ringer’s injection, lactated.

h Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

i Tested in both dextrose 5% and sodium chloride 0.9%.

j Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

k Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

l Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

m Run at 100 mL/hr.

n Not specified whether concentration refers to single component or combined components.

o Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

p Intralipid product.

q SMOFlipid product.